8 Figure 2. Study Treatment Timeline, Doses Scheduled and Follow -up ......................................................... 11 Table 1. Dosing- Eligibility Requirements .................................................................................................... 16 Table 2a. CRS -207 and Pemetrexed/Cisplatin [Cohort 1] .............................................................................. 30 Table 2b. Schedule of Procedures – Low-dose Cy/CRS -207 and Pemetrexed/Cisplatin [Cohort 2] .............. 33 Table 3.